EGFR V802I + KRAS mutation

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.

EGFR V802I + KRAS mutation	Non Small Cell Lung Cancer	EGFR V802I + KRAS mutation	Non Small Cell Lung Cancer	gefitinib Resistant: C3 – Early Trials gefitinib Resistant : C3	gefitinib Resistant: C3 – Early Trials gefitinib Resistant : C3
EGFR V802I + KRAS mutation	Non Small Cell Lung Cancer	EGFR V802I + KRAS mutation	Non Small Cell Lung Cancer	erlotinib Resistant: C3 – Early Trials erlotinib Resistant : C3	erlotinib Resistant: C3 – Early Trials erlotinib Resistant : C3

Associations